Negotiated Medicare prices for 15 prescription drug groups take effect Jan. 1, 2027, but the published amounts do not tell beneficiaries what they will pay at the pharmacy. Their own costs still depend on their coverage.
The Centers for Medicare & Medicaid Services’ November 2025 fact sheet lists the agreed prices.
What do the negotiated prices represent?
CMS negotiates prices for selected high-spending drugs without generic or biosimilar competition. The program calls the resulting amounts maximum fair prices. The agency’s table compares 30-day supply benchmarks with 2024 list prices, rather than with an individual’s previous copayment.
| Drug | 2027 negotiated price | 2024 list price |
|---|---|---|
| Trelegy Ellipta | $175 | $654 |
| Linzess | $136 | $539 |
| Breo Ellipta | $67 | $397 |
| Tradjenta | $78 | $488 |
| Janumet; Janumet XR | $80 | $526 |
Package amounts can differ from the summary benchmark. CMS lists $274 for the Ozempic, Rybelsus and Wegovy group, while its example for a Wegovy package containing four 2.4-milligram pens is $385.63. Neither figure is a universal patient price.
Why can your pharmacy bill differ?
Medicare’s Part D cost guidance separates premiums, deductibles, fixed copayments and percentage-based coinsurance. Those charges depend on the plan. A negotiated drug price and a beneficiary’s share of the bill therefore answer different questions.
For 2027, the maximum Part D deductible is $700, although some plans have no deductible. Covered Part D out-of-pocket spending reaches catastrophic coverage at $2,400, after which beneficiaries pay nothing out of pocket for covered Part D drugs for the rest of the calendar year.
CMS requires Part D formularies to include selected drugs with agreed negotiated prices. That requirement does not establish coverage for every possible use or determine a particular enrollee’s bill.
Medicare’s explanation of drug coverage advises checking the plan’s covered-drug list before enrolling. Plans use cost-sharing tiers, and beneficiaries can ask their plan about coverage rules or an exception when appropriate.
What should you check before Dec. 7?
Medicare’s annual enrollment window closes Dec. 7. Requests received by that deadline take effect Jan. 1, 2027. Depending on current coverage, beneficiaries can change drug plans, change Advantage plans or switch between Original Medicare and Medicare Advantage.
Compare the plan’s estimate for your actual prescriptions and pharmacy alongside its premium and deductible. FingerLakes1’s 2027 plan-cost explainer covers the broader premium projections and spending limits. Its enrollment coverage also identifies New York counseling resources.
In its Sept. 28 enrollment announcement, CMS directs beneficiaries to Medicare Plan Finder and 1-800-MEDICARE for comparisons. National average premiums cannot substitute for a specific plan estimate. People keeping their current coverage generally do not need to re-enroll.
Where can you find general enrollment background?
This CMSHHSgov video, published Oct. 7, 2024, provides general open enrollment background. Use the current written guidance above for 2027 prices and costs.
Make FL1 part of your day.
Local reporting. Useful updates. More ways to stay close to your community.
Go ad-free
Support independent local reporting and enjoy FL1 without display ads.
$4.99 / month
Become a member →Cancel anytime. Third-party media players may contain ads.Get the daily briefing
Start your morning with the headlines that matter across the Finger Lakes.
Find more FL1 on Google
Choose FingerLakes1.com as a preferred source to see more of our reporting in your Google news results.



